Literature DB >> 21862825

The nocebo effect and its relevance for clinical practice.

Luana Colloca1, Franklin G Miller.   

Abstract

Negative expectations deriving from the clinical encounter can produce negative outcomes, known as nocebo effects. Specifically, research on the nocebo effect indicates that information disclosure about potential side effects can itself contribute to producing adverse effects. Neurobiological processes play a role in the nocebo effect, and this article provides a selective review of mechanistic research on the nocebo effect. Comparatively little attention has been directed to clinical studies and their implications for daily clinical practice. The nocebo response is influenced by the content and the way information is presented to patients in clinical trials in both the placebo and active treatment conditions. Nocebo effects adversely influence quality of life and therapy adherence, emphasizing the need for minimizing these responses to the extent possible. Evidence further indicates that the informed consent process in clinical trials may induce nocebo effects. This article concludes with ethical directions for future patient-oriented research and routine practice.

Entities:  

Mesh:

Year:  2011        PMID: 21862825      PMCID: PMC3167012          DOI: 10.1097/PSY.0b013e3182294a50

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  55 in total

Review 1.  New insights into the placebo and nocebo responses.

Authors:  Paul Enck; Fabrizio Benedetti; Manfred Schedlowski
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

Review 2.  A systematic review of adverse events in placebo groups of anti-migraine clinical trials.

Authors:  Martina Amanzio; Luca Latini Corazzini; Lene Vase; Fabrizio Benedetti
Journal:  Pain       Date:  2009-09-24       Impact factor: 6.961

Review 3.  Nonspecific medication side effects and the nocebo phenomenon.

Authors:  Arthur J Barsky; Ralph Saintfort; Malcolm P Rogers; Jonathan F Borus
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

Review 4.  Presenting risk information--a review of the effects of "framing" and other manipulations on patient outcomes.

Authors:  A Edwards; G Elwyn; J Covey; E Matthews; R Pill
Journal:  J Health Commun       Date:  2001 Jan-Mar

5.  Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".

Authors:  Elizabeth B Lamont; Nicholas A Christakis
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

6.  Nocebo-induced hyperalgesia during local anesthetic injection.

Authors:  Dirk Varelmann; Carlo Pancaro; Eric C Cappiello; William R Camann
Journal:  Anesth Analg       Date:  2009-12-30       Impact factor: 5.108

7.  Conditioning and hyperalgesia in newborns exposed to repeated heel lances.

Authors:  Anna Taddio; Vibhuti Shah; Cheryl Gilbert-MacLeod; Joel Katz
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

8.  Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer.

Authors:  Maxine de la Cruz; David Hui; Henrique A Parsons; Eduardo Bruera
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

9.  Placebo adverse events in headache trials: headache as an adverse event of placebo.

Authors:  U Reuter; M Sanchez del Rio; J A Carpay; C J Boes; S D Silberstein
Journal:  Cephalalgia       Date:  2003-09       Impact factor: 6.292

10.  Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo.

Authors:  Antonello Silvestri; Pasquale Galetta; Elena Cerquetani; Giuseppe Marazzi; Roberto Patrizi; Massimo Fini; Giuseppe M C Rosano
Journal:  Eur Heart J       Date:  2003-11       Impact factor: 29.983

View more
  95 in total

Review 1.  Nocebo in headaches: implications for clinical practice and trial design.

Authors:  Dimos D Mitsikostas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  The placebo phenomenon: implications for the ethics of shared decision-making.

Authors:  Howard Brody; Luana Colloca; Franklin G Miller
Journal:  J Gen Intern Med       Date:  2012-01-19       Impact factor: 5.128

3.  Adverse events during placebo vs. no drug administration--results of a randomised interventional trial in 160 volunteers.

Authors:  Frank Erbguth; Angelika Hamacher-Erbguth; Uwe Fuhr; Fritz Sörgel
Journal:  Eur J Clin Pharmacol       Date:  2015-08-14       Impact factor: 2.953

Review 4.  The placebo effect: From concepts to genes.

Authors:  B Colagiuri; L A Schenk; M D Kessler; S G Dorsey; L Colloca
Journal:  Neuroscience       Date:  2015-08-10       Impact factor: 3.590

Review 5.  Understanding placebo and nocebo responses for pain management.

Authors:  Luana Colloca; Christian Grillon
Journal:  Curr Pain Headache Rep       Date:  2014-06

6.  Short-term side-effects of brain MR examination at 7 T: a single-centre experience.

Authors:  M Cosottini; D Frosini; L Biagi; I Pesaresi; M Costagli; G Tiberi; M Symms; M Tosetti
Journal:  Eur Radiol       Date:  2014-05-10       Impact factor: 5.315

7.  Preface: Part II: The Fascinating Mechanisms and Implications of the Placebo Effect.

Authors:  Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018       Impact factor: 3.230

8.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.

Authors:  Matthew J Coleshill; Louise Sharpe; Luana Colloca; Robert Zachariae; Ben Colagiuri
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

Review 9.  Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit.

Authors:  Beth D Darnall; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

10.  Enhancing shared decision making about discontinuation of antidepressant medication: a concept-mapping study in primary and secondary mental health care.

Authors:  Carolien Wentink; Marloes J Huijbers; Peter Lbj Lucassen; Annoek van der Gouw; Cornelis Kramers; Jan Spijker; Anne Em Speckens
Journal:  Br J Gen Pract       Date:  2019-10-31       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.